Peregrine Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-125,653
| Closed | -$5.99M | – | 347 |
|
|
2021
Q4 | $5.99M | Buy |
125,653
+23,001
| +22% | +$1.1M | 0.12% | 244 |
|
|
2021
Q3 | $6.82M | Sell |
102,652
-20,331
| -17% | -$1.35M | 0.14% | 240 |
|
|
2021
Q2 | $9.6M | Buy |
122,983
+25,968
| +27% | +$2.03M | 0.17% | 236 |
|
|
2021
Q1 | $9.18M | Sell |
97,015
-13,570
| -12% | -$1.28M | 0.17% | 239 |
|
|
2020
Q4 | $13.5M | Buy |
110,585
+11,584
| +12% | +$1.41M | 0.26% | 186 |
|
|
2020
Q3 | $8.65M | Buy |
+99,001
| New | +$8.65M | 0.23% | 149 |
|